DNL-0300

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDNL-0300
Drug Alias Nametestosterone replacement therapy (Diurnal)orally-active native testosterone (Diurnal)androgen receptor agonist (Diurnal)DITESTDNL-0300
ClassificationSmall molecules > Lipid
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsHypogonadism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDiurnal Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDiurnal Ltd
Inactive CompaniesN/A
Active IndicationsHypogonadism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A